The lower in paclitaxel CL noticed during the existence of zosuquidar resulted in a increase in some time the plasma paclitaxel focus stays previously mentioned 0.1 mol L−one, which is known to become a marker of both toxicity (neutropenia) and efficacy [one]. Although the effect of zosuquidar over the toxicity https://joycey110lwh4.wikilima.com/user